|
Granulocytic series
| | | | |
|
Abnormal granularity
|
0
|
17
|
3
|
0.001
|
|
Abnormal decrease in CD45 expression
|
3
|
9
|
1
|
0.245
|
|
Abnormal pattern in CD13/CD16
|
2
|
23
|
8
|
0.0001
|
|
Abnormal pattern in CD33/HLA-DR
|
7
|
26
|
9
|
0.0001
|
|
Expression of CD56
|
0
|
9
|
1
|
0.018
|
|
Aberrant expression of CD34
|
1
|
7
|
3
|
0.06
|
|
Aberrant expression of CD7
|
1
|
2
|
1
|
0.776
|
|
Aberrant expression of CD19
|
0
|
4
|
0
|
0.101
|
|
Asynchronous shift to the left
|
7
|
11
|
6
|
0,227
|
|
Monocytes series
| | | | |
|
Abnormal granularity
|
7
|
12
|
0
|
0.10
|
|
Abnormal % Monocytes
|
11
|
27
|
9
|
0.04
|
|
Increase of % Monocytes CD16+
|
8
|
19
|
8
|
0.015
|
|
Abnormal pattern in CD33/HLA-DR
|
5
|
21
|
2
|
0.01
|
|
Expression of CD56
|
6
|
14
|
3
|
0.20
|
|
Aberrant expression of CD34
|
1
|
17
|
6
|
<0.0001
|
|
Aberrant expression of CD7
|
1
|
9
|
5
|
0.008
|
|
Aberrant expression of CD19
|
1
|
5
|
2
|
0.278
|
|
Cells in the blast gate
| | | | |
|
Increase of % CD34+ cells
|
1
|
11
|
10
|
<0.0001
|
|
Increase of % CD34+/CD13+/CD117+
|
4
|
18
|
9
|
0.001
|
|
Anomalous expression of CD7
|
0
|
9
|
8
|
<0.0001
|
|
Anomalous expression of CD56
|
2
|
15
|
9
|
<0.0001
|
